Expired Canadian patentCanada
Hcv anti-core monoclonal antibodies
CA 2406240 C · Owner: Ortho-Clinical Diagnostics, Inc. · Inventors: Bahl, Chander
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Monoclonal antibodies that specifically bind to HCV core antigen. Also provided are hybridoma cell lines which secrete these antibodies methods for making and using these antibodies including kits that include these antibodies.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 5, 2002 and granted January 4, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 5, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 5, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 5, 2002
GrantedJanuary 4, 2011
Term endedNovember 5, 2022
Patent numberCA 2406240 C
Classification (IPC)C12N5/12 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.